Dr Stephen John Sammut

June 15, 2020

Stephen is a medical oncologist who’s current research interests include the application of machine learning to capture and integrate serial multimodal data obtained during neoadjuvant chemotherapy. By combining features derived from breast tumour molecular profiling, advanced imaging analysis, digital pathology and circulating biomarkers he is developing models that are predictive of response to chemotherapy and charting the dynamic evolution of tumours as they are subjected to chemotherapy.

 

Dr Stephen John Sammut
Connect

Connect with us

The Mark Foundation Institute for Integrated Cancer Medicine (MFICM) at the University of Cambridge aims to revolutionise cancer care by affecting patients along their treatment pathway.

Find out more

Connect